A detailed history of Close Asset Management LTD transactions in Guardant Health, Inc. stock. As of the latest transaction made, Close Asset Management LTD holds 460 shares of GH stock, worth $21,610. This represents 0.0% of its overall portfolio holdings.

Number of Shares
460
Previous 460 -0.0%
Holding current value
$21,610
Previous $11,000 27.27%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 11, 2023

BUY
$25.8 - $39.97 $2,064 - $3,197
80 Added 21.05%
460 $14,000
Q2 2023

Jul 26, 2023

BUY
$20.94 - $38.01 $1,256 - $2,280
60 Added 18.75%
380 $14,000
Q1 2023

Apr 19, 2023

BUY
$22.92 - $33.76 $1,375 - $2,025
60 Added 23.08%
320 $8,000
Q4 2022

Jan 27, 2023

BUY
$25.44 - $59.78 $6,614 - $15,542
260 New
260 $7,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $4.8B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Close Asset Management LTD Portfolio

Follow Close Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Close Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Close Asset Management LTD with notifications on news.